Cross-institution positioning
Jul 31, 2026Strong institutional reduction. 1 reducing, 2 exited across 3 comparable institutions.
Source: Schedule 13 researchEnova International, Inc.
Latest stored close $182.59 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 reducing, 2 exited across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 5 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/59 non-amendment material events in the last 90 days; 4 capital-related filing/events (0 equity-related, 4 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +21.6% YoY; Net income +38.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 43% through its reported 52-week range; +48.8% over one year.
Source: Stored historical price seriesFiled Jul 31, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Fisher David | MExercise or conversion of derivative · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 20.8K | $0.00 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Fisher David | SOpen-market or private sale | Common stock, par value $0.00001 per share | 20.8K | $178.24 | Direct | Sep 21, 2026 |
| Sep 17, 2026 | Fisher David | MExercise or conversion of derivative | Common stock, par value $0.00001 per share | 20.8K | $20.73 | Direct | Sep 21, 2026 |
| Aug 26, 2026 | Fisher David | MExercise or conversion of derivative · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 9.1K | $0.00 | Direct | Aug 27, 2026 |
| Aug 26, 2026 | Fisher David | SOpen-market or private sale | Common stock, par value $0.00001 per share | 9.1K | $239.16 | Direct | Aug 27, 2026 |
| Aug 26, 2026 | Fisher David | MExercise or conversion of derivative | Common stock, par value $0.00001 per share | 9.1K | $20.73 | Direct | Aug 27, 2026 |
| Aug 25, 2026 | Fisher David | MExercise or conversion of derivative · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 9.5K | $0.00 | Direct | Aug 27, 2026 |
| Aug 25, 2026 | Fisher David | SOpen-market or private sale | Common stock, par value $0.00001 per share | 9.5K | $244.01 | Direct | Aug 27, 2026 |
| Aug 25, 2026 | Fisher David | MExercise or conversion of derivative | Common stock, par value $0.00001 per share | 9.5K | $20.73 | Direct | Aug 27, 2026 |
| Aug 5, 2026 | Rahilly Sean | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 1.5K | $0.00 | Direct | Aug 7, 2026 |
| Aug 5, 2026 | Cunningham Steven E | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 7.4K | $0.00 | Direct | Aug 7, 2026 |
| Aug 5, 2026 | Fisher David | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 6.2K | $0.00 | Direct | Aug 7, 2026 |
| Aug 5, 2026 | Cornelis Scott | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 1.5K | $0.00 | Direct | Aug 7, 2026 |
| Aug 5, 2026 | Chartier Kirk | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 2.1K | $0.00 | Direct | Aug 7, 2026 |
| Aug 5, 2026 | Veltre Maria | AGrant, award, or other acquisition | Common stock, par value $0.00001 per share | 772 | $0.00 | Direct | Aug 7, 2026 |
| Jul 15, 2026 | Fisher David | MExercise or conversion of derivative · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 11.5K | $0.00 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Fisher David | SOpen-market or private sale | Common stock, par value $0.00001 per share | 11.5K | $231.45 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Fisher David | MExercise or conversion of derivative | Common stock, par value $0.00001 per share | 11.5K | $20.73 | Direct | Jul 16, 2026 |
| Jul 14, 2026 | Fisher David | MExercise or conversion of derivative · derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 17.0K | $0.00 | Direct | Jul 16, 2026 |
| Jul 14, 2026 | Fisher David | SOpen-market or private sale | Common stock, par value $0.00001 per share | 17.0K | $231.51 | Direct | Jul 16, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 25, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Sep 17, 2026 | 8-K | 1.01, 2.03 | Material definitive agreement; New direct financial obligation | Debt | Filing |
| Sep 15, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Sep 14, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Sep 9, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 21, 2026 | 8-K | 1.01, 2.03 | Material definitive agreement; New direct financial obligation | Debt | Filing |
| Aug 14, 2026 | 8-K | 1.01, 2.03, 8.01 | Material definitive agreement; New direct financial obligation; Other event | Debt | Filing |
| Jul 23, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 15, 2026 | 8-K/AAmendment | 5.02 | Director or executive change | — | Filing |
| Jul 10, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Jun 25, 2026 | 8-K | 1.01, 2.03 | Material definitive agreement; New direct financial obligation | Debt | Filing |
| May 13, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $928.9M | +21.6% |
| Ended Mar 31, 2026 | $875.1M | +17.4% |
| Ended Sep 30, 2025 | $802.7M | +16.3% |
| Ended Jun 30, 2025 | $764.0M | +21.6% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $3.2B | +18.6% |
| Ended Dec 31, 2024 | $2.7B | +25.5% |
| Ended Dec 31, 2023 | $2.1B | +22.0% |
| Ended Dec 31, 2022 | $1.7B | +43.7% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.1M | $182.59 | |||
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 observed Jul 31, 2026 filed · 31d Initial Schedule 13G | Initial Schedule 13G | 1.3M | 12.00% | $240.73 | $254.14 | $182.59 |
| BlackRock CIK0002012383 | Mar 31, 2026 observed Apr 24, 2026 filed · 24d Schedule 13G amendment | Reported reduction | 3.4M -371.1K | 13.80% -1.00 pts | $135.83 | $166.65 | $182.59 |
Compare ENVA with other securities showing similar institutional activity or recent accumulation across several tracked institutions.